Richard Maziarz, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Athersys
    Topic:
    Mesenchymal stromal cells
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Topic:
    CAR T
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Kite
    Topic:
    CAR T
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Allovir
    Topic:
    T cell therapy
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Artiva
    Topic:
    Cell Therapy
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Orca Biotech
    Topic:
    Stem cell transplant
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gamida
    Topic:
    Cord blood transplant
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Vor Pharma
    Topic:
    Stem cell transplant
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Century Therapeutics
    Topic:
    Cell Therapy
    Date added:
    06/30/2023
    Date updated:
    06/30/2023
Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes